Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase EARLY_PHASE1 1

Status

Completed 3Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 5OTHER_GOV 1

Study Type

Interventional 5Observational 4

Sponsor

Cancer Type

Dermatologic 4Sarcoma 1

Conditions

Carcinoma, Basal Cell 3Skin Neoplasms 2Carcinoma, Squamous Cell 2Eyelid Neoplasms 1Dermatofibrosarcoma 1Adenocarcinoma, Sebaceous 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1199Oxaliplatin 1160Capecitabine 1144Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Interventional × Mohs Surgery × Clear all
NCT07241585 2026-03-17

Vitamin D Effects on Immune Microenvironment of Nonmelanoma Skin Cancer After Photodynamic Therapy (PDT)

Case Comprehensive Cancer Center

Phase NA Not yet recruiting
54 enrolled
Dermatologic

Carcinoma, Basal Cell, Carcinoma, Squamous Cell

NCT05072327 2021-10-08

Mohs Surgery Combind With Cryotherapy for Eyelid Malignant Tumors.

Sun Yat-sen University

Phase NA Unknown
120 enrolled
Dermatologic

Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Eyelid Neoplasms, Adenocarcinoma, Sebaceous

NCT03381846 2020-08-05

Treatment of Dermatofibrosarcoma Protuberans in Patients 10 Years and Younger

Mayo Clinic

Phase NA Completed
7 enrolled
Sarcoma

Dermatofibrosarcoma

NCT02373722 2018-07-03

Website Application Based Education and Text Messaging in Improving Skin Wound Care in Patients Undergoing Mohs Surgery

Wake Forest University Health Sciences

Phase NA Completed
90 enrolled
Dermatologic

Skin Neoplasms

NCT01631331 2017-12-08

Vismodegib in Treating Patients With Basal Cell Carcinoma (BCC)

Stanford University

Phase EARLY_PHASE1 Completed
15 enrolled 10 charts
Dermatologic

Carcinoma, Basal Cell, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡